Dow Up 1.31% Nasdaq Up 2.40%

Agenus Inc. (AGEN)

-NasdaqCM
3.00 Up 0.02(0.67%) Oct 21, 4:00PM EDT
Prev Close:2.98
Open:2.98
Bid:2.92 x 600
Ask:3.03 x 5000
1y Target Est:7.00
Beta:1.82
Next Earnings Date:N/A
Day's Range:2.89 - 3.03
52wk Range:2.27 - 5.27
Volume:169,829
Avg Vol (3m):1,041,590
Market Cap:188.04M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AGENUp 0.67%188.04M
ABPIDown 29.58%448.78K
DNDNDown 2.65%170.97M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):37.94
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.50
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Agenus Inc., a biopharmaceutical company, is developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines, and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback